Quantcast

Latest Hepatology Stories

2014-10-22 16:28:46

FLINT, Mich., Oct. 22, 2014 /PRNewswire/ -- U.S. Food and Drug Administration (FDA) announced October 10, 2014 that Gilead Sciences Harvoni(® )(ledipasvir/sofosbuvir) product was approved for the treatment of chronic hepatitis C, genotype 1 infection in adults. Harvoni(®) is the first oral combination therapy approved for the treatment of hepatitis C and is also the first treatment regimen that does not require administration with pegylated interferon or ribavirin....

2014-10-22 12:29:19

Boston, MA - Hynes Convention Center, November 7 - 11, 2014 ALEXANDRIA, Va. and BOSTON, Oct. 22, 2014 /PRNewswire/ -- The Liver Meeting® is the premier Annual Meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments, and the results from pilot and multicenter studies. Approximately 10 percent of Americans have some form of liver disease, but fortunately, the research community has made great strides in recent years in developing new...

2014-10-16 08:31:16

SAN ANTONIO, Texas, October 16, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, today announced that Melanie Thomas, MD, MS, a recognized worldwide leader in the field of liver cancer, will join the company as Medical Advisor. Dr. Thomas most recently held the Grace E. DeWolff Chair in Gastrointestinal Oncology at the Medical University of South Carolina and served as Associate Director of Clinical...

2014-10-13 08:26:44

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2014 /PRNewswire/ -- Tobira Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today that it has dosed the first patient in its CENTAUR study of patients with non-alcoholic steatohepatitis (NASH) and liver fibrosis, a disease affecting approximately 3-5 percent of the U.S. population. The initiation of the CENTAUR study follows the completion of a Phase 1 safety study in...

Researchers Identify Epigenetic Changes Caused By Binge Drinking
2014-10-10 03:38:43

Provided by University of Missouri School of Medicine Overconsumption of alcohol triggers inflammatory response in the liver Researchers at the University of Missouri School of Medicine have identified epigenetic protein changes caused by binge drinking, a discovery that could lead to treatments for alcohol-related liver diseases. “We know that chronic alcohol use is damaging to the liver, but binge drinking amplifies that damage,” said Shivendra Shukla, PhD, Margaret Proctor...

2014-10-09 08:27:33

SAN ANTONIO, Texas, October 9, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, today announced that patient enrollment has been completed in the company's Phase II clinical trial in patients with liver cancer (hepatocellular carcinoma). Formal results of the study are expected to be available during the first quarter of 2015. "We are grateful to the trial investigators for their efforts, as well as the...

2014-10-07 08:28:48

University of Mannheim Medical Center is first site opened TORONTO and CHICAGO, Oct. 7, 2014 /PRNewswire/ - Pinnacle Biologics, Inc. ("Pinnacle"), a subsidiary of Concordia Healthcare Corp., ("Concordia") (TSX: CXR) (OTCQX: CHEHF), announced today the initiation of the pivotal Phase 3 trial (OPUS) in Germany for a rare form of bile duct cancer for which there is currently no acceptable therapy. OPUS is an Open-label, multicenter phase 3 on the efficacy and safety of Photodynamic...

2014-10-07 08:28:45

PETACH TIKVA, Israel, Oct. 7, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced the Company's CEO, Dr. Pnina Fishman, will co-chair the Cancer Therapeutics session of the 19th World Congress on Advances in Oncology. The conference will take place in Athens, Greece, from October 9-11, 2014. In addition to co-chairing...

2014-10-06 23:07:04

Regarded as one of the world's leading experts in the field of pediatric inflammatory bowel disease (IBD), Marla Dubinsky, MD, has been appointed Chief of Pediatric Gastroenterology in the Jack and Lucy Clark Department of Pediatrics at the Kravis Children's Hospital at Mount Sinai, and Co-Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center. New York, New York (PRWEB) October 06, 2014 Regarded as one of the world's leading experts in the...

2014-09-30 08:31:31

CF102 has shown to induce healthy liver cell proliferation resulting in improved liver status PETACH TIKVA, Israel, Sept. 30, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced the United States Patent and Trademark Office has issued a patent to the Company which covers its drug candidate, CF102, in the treatment of...


Latest Hepatology Reference Libraries

Chinese Liver Fluke, Clonorchis sinensis
2014-01-12 00:00:00

The Chinese liver fluke (Clonorchis sinensis) is a species of parasitic worm that is classified within the Platyhelminthes phylum. It can be found in Southeast Asia, Taiwan, Japan, and China and is present in nearly 30,000,000 humans today. It is thought to be one of the world’s most pervading parasites. The Chinese liver fluke requires two intermediate, or secondary, hosts and one definitive, or main, host to successfully complete its lifecycle. The first intermediate host is typically...

Southeast Asian Liver Fluke, Opisthorchis viverrini
2014-01-12 00:00:00

The Southeast Asian liver fluke (Opisthorchis viverrini) is a parasite that is classified within the Platyhelminthes phylum. It is native to Vietnam, Cambodia, Thailand, and the Lao People's Democratic Republic. It occurs in higher numbers in northern areas of Thailand when compared to central areas of Thailand, and the disease the worm causes, known as opisthorchiasis, does not occur in southern areas of Thailand. The Southeast Asian liver fluke is so small that it can only be seen under...

Echinococcus multilocularis
2014-01-12 00:00:00

Echinococcus multilocularis is a species of tapeworm that is classified within the Platyhelminthes phylum. It is one of a few worms that cause echinococcosis, a disease that affects many canid species including wolves, coyotes, foxes, jackals, domesticated dogs. Humans can also contract this disease. Adult members of this species can reach an average length of .2 inches, and like other species of tapeworm, its body is segmented by three proglottids. Its head, or scolex, is equipped with...

Liver
2013-04-30 14:18:06

The liver is the organ in charge of processing, neutralizing and excreting certain secretions for the metabolic processes. Formation and Orientation The liver is considered to be both the largest internal organ and the largest gland in the human body. It is situated just below the diaphragm, to the right of the stomach and on top of the gallbladder. There are two ways blood can travel to and from the liver: the hepatic artery and the portal vein. The hepatic artery carries blood solely...

Gallbladder
2013-03-05 14:18:48

The gall bladder is the sac-shaped organ that is the passage between the liver and intestine where bile is held. Formation and Orientation The gall bladder is relatively 8 cm by 4 cm when fully formed. The gallbladder is angled between the rectus abdominis muscle and the costal margin. It is hollow and is made up of three parts; the fundus, the body and the neck. The fundus is the part of the gallbladder that is most far from the cystic duct. This is at the same level of the...

More Articles (6 articles) »
Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.